Business Context and Reporting Period
Company: Artelo Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 15, 2019
Reporting Period: Quarter ended May 31, 2019
Status: Emerging Growth Company
This filing serves to report the issuance of a press release regarding the company's financial results for the quarter ended May 31, 2019. The detailed financial data is contained in the attached press release (Exhibit 99.1) and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1), which is not part of the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the quarter ended May 31, 2019, were reported via press release.
Guidance, Outlook, and Risks
The text does not include specific management commentary, guidance, outlook, risks, contingencies, or unusual items. The filing explicitly states that the information is furnished via an attached exhibit and is not incorporated by reference into this specific document text.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific financial figures for the quarter ended May 31, 2019.
- Verify the company's status as an Emerging Growth Company and any associated accounting standard elections.
- Confirm that the press release details are not legally deemed "filed" under Section 18 of the Exchange Act unless expressly referenced in future filings.